Lifestyle program for people with Parkinson's disease or REM sleep behavior disorder
Tests whether people with Parkinson's or REM sleep behavior disorder can follow a lifestyle program.
Plain-language title generated from the registry record
Registry title: Prevention-in-PD-Study
Key facts
- Where
- Kiel, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 85 years old?
Source: NCT07297407, who can take part
Where in Germany
- University Hospital of Schleswig Holstein Campus KielKiel, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Schleswig-Holstein
- Trial code
- NCT07297407
- Record updated
- 15 October 2026
- Original description
The goal of this clinical trial (feasibility study) is to learn if a multimodal lifestyle program can improve adherence to recommended lifestyle changes in people with REM Sleep Behavior Disroder (RBD) or Parkinson's disease (PD).Read full original descriptionShow less
PREVENTION-IN-PD - Development of a Multidomain Lifestyle Intervention Study for Prodromal and Clinical Parkinson's Disease
The goal of this clinical trial (feasibility study) is to learn if a multimodal lifestyle program can improve adherence to recommended lifestyle changes in people with REM Sleep Behavior Disroder (RBD) or Parkinson's disease (PD).
The main question it aims to answer is if individuals with RBD oder PD can follow a combined lifestyle program over six months Participants will take part in a six-month intervention program that includes: Physical training, Mediterranean diet counseling, Sleep counseling and cognitive training.
The program will be supported by psychoeducation, skills training, and personalization to make it practical and motivating.
Inclusion: All participants: ability to perform informed consent; age 30-85; RBD group: polysomnographic proven diagnosis of isolated REM sleep behavior disorder (iRBD); PD group: early to moderate disease (Hoehn \& Yahr stage 1-2.5), diagnosis according to the Movement Disorder Society diagnostic criteria for clinical Parkinson's Disease; Agreement to participate in group sessions and online meetings.
Exclusion: Planned change in medication within the following 6 months; dementia (Mini Mental Score, MMSE < 19 points) (MMSE is specifically chosen here to avoid too frequent repetitions of the MoCA, which is used as an outcome parameter for the interventional trial); other significant diseases of the central nervous system; physical inability to perform exercise training or other trainings as judged by a physician; manifest (severe) depression (Beck Depression Inventory, BDI-II > 29 points); participation in other interventional trials.